David Parrish expects AI to be among the major talking points for a newly formed committee aimed at protecting the interests ...
Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical ...
A new survey by Arnold & Porter reveals that AI adoption in life sciences is accelerating, driving innovation in drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback